Accomplished Product Strategy and Commercialization Director with 12 years' experience and a proven record of success leading various business-related activities in the biopharmaceutical industry.Proficient at distilling data into actionable plans by connecting clinical rationale with commercialization and financial analysis. Guides the development of novel therapeutics by interweaving data with analysis to help a company tell a compelling value story, create an integrated development plan, and make investment decisions (pipeline prioritization). Provides a realistic value proposition by leading the cross-functional design of clinical trials to confirm the target product profile.Works effectively with internal departments to create program and pipeline strategies for an asset. Summarizes findings into a package readily useful for investors so that firms can raise the necessary funds required for clinical trials or boost market capitalization through the communication of reliable forecasts and commercial analysis. Has built up Knowledge Capital that is applicable across most therapeutic areas, modalities, and phases of development; this is deployable for all drugs under development to improve their odds of clinical and commercial success. AREAS OF EXPERTISE▪ Search and Evaluation▪ Indication Prioritization▪ Drug-Indication Financial Models▪ Product Lifecycle Mapping▪ Target Product Profiles▪ Patient Segmentation (disease segmentation by subtypes, therapeutic objectives, or disease progression/staging)▪ Commercialization Analysis▪ Clinical Unmet Need Analysis ▪ AI-enhanced Pipeline and Portfolio Strategy ▪ AI-enhanced Research▪ Pipeline Strategy and Valuation (Non-Correlated and Correlated Asset Portfolios)▪ Marketing to Investors